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Abstract
Background: Parametric modelling of survival data is important and reimbursement decisions may
depend on the selected distribution. Accurate predictions require sufficiently flexible models to
describe adequately the temporal evolution of the hazard function. A rich class of models is available
among the framework of generalised linear models (GLMs) and its extensions, but these models are
rarely applied to survival data. This manuscript describes the theoretical properties of these more
flexible models, and compares their performance to standard survival models in a reproducible case-
study.
Methods: We describe how survival data may be analysed with GLMs and its extensions: fractional
polynomials, spline models, generalised additive models, generalised linear mixed (frailty) models and
dynamic survival models. For each, we provide a comparison of the strengths and limitations of these
approaches. For the case-study we compare within-sample fit, the plausibility of extrapolations and
extrapolation performance based on data-splitting.
Results: Viewing standard survival models as GLMs shows that many impose a restrictive assumption
of linearity. For the case-study, GLMs provided better within-sample fit and more plausible
extrapolations. However, they did not improve extrapolation performance. We also provide guidance
to aid in choosing between the different approaches based on GLMs and its extensions.
Conclusions: The use of GLMs for parametric survival analysis can out-perform standard parametric
survival models, although the improvements were modest in our case-study. This approach is currently
seldom used. We provide guidance on both implementing these models and choosing between them.
The reproducible case-study will help to increase uptake of these models.
Keywords
survival analysis, time to event, generalised additive models, dynamic survival models, generalised
linear mixed models, splines, fractional polynomials, frailty models
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1 Introduction
In many medical studies the outcome of interest is the time until an event occurs. Examples
include mortality, disease progression, or hospital admission. To aid with decision-making the
hazard function is estimated from parametric models. A prominent example is health technology
assessment (HTA), which aims to quantify both the benefits to patients and the costs a healthcare
system would occur if a treatment were funded [1]. To allow for fair comparisons across different
treatments it is important that all relevant benefits and costs are quantified, which often requires
use of a lifetime horizon [2]. However, time-to-event (TTE) data with complete follow-up are
rarely available. As such, parametric models may be used to extrapolate model-outcomes to a
lifetime, and hence obtain estimates of mean TTE (such as mean survival) [3, 4].
Standard one and two parameter models are available, including the exponential, Weibull,
Gompertz, log-logistic and lognormal [5]. However, these models may not be sufficiently flexible
to capture complex, time-varying hazards [6, 7]. In Section 2 we introduce generalised linear
models (GLMs) and show that standard survival models may be expressed as GLMs. This
provides insight into the limitations of the standard models: they all impose an assumption of
linearity. More flexible parametric models that relax this assumption are required. A number of
these have been proposed within the framework of GLMs and its extensions, but to-date they
are seldom used to analyse TTE. These are described in Sections 3 and 4, with an overview in
Section 5. An application of these is described in in Section 6, which demonstrates that the GLM-
based models can provide superior within-sample estimates and more plausible extrapolations
than standard survival models. Concluding remarks are provided in Section 7.
This manuscript has two aims. The first is to propose the use of GLMs for the analysis of
TTE data. This includes flexible GLMs such as fractional polynomials (FPs) and restricted cubic
splines (RCS), which are closely related to Royston-Parmar (R-P) models. The second aim is
to present generalisations to GLMs: generalised linear mixed models (GLMMs) [8], generalised
additive models (GAMs) [9] and dynamic generalised linear models (DGLMs) [10, 11].
2 Analysing time-to-event data within a generalised linear modelling
framework
2.1 Standard survival models as linear models
The framework of GLMs extends (generalises) the standard linear model to response variables
with distributions in the exponential family, including Normal, Poisson, Binomial, Gamma and
1The University of Sheffield
2The University of York
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Inverse Gaussian distributions [12]. An advantage of GLMs is that they provide a unified
framework - both theoretical and conceptual - for the analysis of many problems, including
linear, logistic and Poisson regression [13]. A random variable Y belongs to the exponential
family of distributions if its probability density (or mass) function can be written as:
f(yt; θ) = exp[a(y)b(θ) + c(θ) + d(y)] (1)
where a(y) and d(y) are functions of the data, whilst b(θ) and c(θ) are functions of the distribution
parameter θ and assumed to be twice differentiable. Equation (1) may also include other
parameters, which are treated as nuisance parameters [13]. Examples for the Normal, Poisson
and Binomial distributions are provided in Table 1. For these, a(y) = y.
Table 1. Normal, Poisson and Binomial distributions as members of the exponential family
Distribution b(θ) c(θ) d(y)
Normal µ
σ2
- µ
2
2σ2
−
1
2
log(2piσ2) −y
2
2σ2
Poisson log θ −θ − log y!
Binomial log( pi
1−pi
) n log(1− pi) log
(
n
y
)
µ and σ2 are a mean and variance, pi is a probability, n the
number of trials and
(
n
y
)
=
n!
y!(n−y)!
is the binomial coefficient.
For a TTE GLM, the observed outcome is the number of deaths during an interval: yt. This
is linked to the at-risk population at time t (denoted by τt) using a distribution from the
exponential family. Use of the Poisson distribution assumes that yt = τt × λt where λt is the
hazard at time t. Alternatively, use of the Binomial distribution assumes that yt = τ1 × pt where
pt is the cumulative probability of death. Model specification is [12]:
Observation model: E[yt] = µt × τt, yt ∼ exponential family distribution (2a)
Response function: µt = h(x
T
t β) (2b)
where E[·] denotes the expected value, bold font denotes a vector, and:
β is a vector of parameter coefficients to be estimated from the data,
xt is a covariate, assumed known (with transpose x
T
t ), and
h() is a one-to-one response function which maps the linear predictor (xTt βt) to µt. Its
inverse is known as the link function, and is denoted as g().
Model parameters may be obtained via maximum likelihood estimation. The general expression
for the logarithm of the likelihood is:
logL =
N∑
t=1
Lt =
N∑
t=1
ytb(θt) +
N∑
t=1
c(θt) +
N∑
i=t
d(yt)
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Where N is the number of time-intervals. For the Poisson and Binomial models, this becomes:
Poisson: logL =
N∑
t=1
[yt log(θt)− θt − log(yt!)] (3a)
Binomial: logL =
N∑
t=1
[
yt log
(
pit
1− pit
)
+ nt log(1− pit) + log
(
nt
yt
)]
(3b)
In summary, a GLM may be specified by three components:
1. The distribution from the exponential family, as defined in equation (1),
2. the response (or link) function, and
3. the covariate vector.
For survival analyses, options for µt include the (cumulative) survival function, its complement
the (cumulative) failure function, the hazard function, and the cumulative hazard function - see
[5, 14] for more details. Depending on th specification, we can express standard survival models
as a linear model: µt = β0 + β1xt. Table 2 provides these specifications. The log-logistic and
lognormal distributions have a cumulative function as their outcome. It would not be sensible to
model such an outcome as a constant value which demonstrates why there is no single-parameter
special case of these models. In contrast, the Weibull and Gompertz distributions model a non-
cumulative outcome, so it is possible to model this as a single value, resulting in the exponential
model.
Table 2. Specification of standard survival models as generalised linear models
µt Distribution Response function Covariate Model
Hazard Poisson Exponential None Exponential
Hazard Poisson Exponential Time Gompertz
Hazard Poisson Exponential Log(time) Weibull
Cumulative Failure Binomial Logistic Log(time) Log-logistic
Cumulative Failure Binomial Inverse probit Log(time) Lognormal
An important aspect of survival data is that there is typically censoring of observations.
Censoring occurs because for standard models the outcome is the time of the event occurring, and
for some individuals the event is not observed (so it is censored). Within the GLM formulation,
time changes from being the outcome to a covariate, so there are no censored observations.
Information on censoring is included by calculating the ‘at-risk’ sample, and including this
information in the model. For models with a binomial distribution there is an explicit parameter
for the sample size. For models with a Poisson distribution, information on the sample size may
be incorporated as an ‘offset’ term.
Prepared using sagej.cls
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2.2 Limitations with linearity
The assumption of linearity may not always be realistic. For example, for overall survival the
hazard of all-cause mortality will increase over time due to patient ageing. In contrast, frailty
effects may result in disease-specific mortality decreasing over time (as those with an increased
hazard will die sooner, leaving those with a lower hazard). The impact of treatment on survival
may also vary over time: there may be an initial elevated risk of death due to adverse events;
treatment-related toxicities may increase other-cause mortality over time, treatment stopping
rules and trial inclusion criteria may have an effect [15]. These considerations motivate the need
for more flexible survival models, which are considered within the GLM framework in the next
two Sections.
3 Relaxing the assumption of linearity
We briefly describe flexible models that may be applied to survival data within a GLM
framework, more details are provided in the Appendix. Without loss of generality, y is used
to denote either a random variable or the observed data.
3.1 Fractional polynomials
FPs represent the outcome as a sum of polynomial terms; increasing the number of terms (the
order of the FP) increases the flexibility of the model. A closed-test procedure may be used to
identify the order. For a single variable, an ith order FP is defined as:
E(yt) = FP(i) = β0 +
i∑
j=1
βjx
pj (4)
where the set of powers pj is pre-specified, and may include fractional powers (hence the name
fractional polynomials). FPs include linear models as special cases, so depending on specification
may include one of the standard models from Table 2. Some limitations with FPs are that they
may not have sufficient power to detect non-linearity, and they can be sensitive to extreme values
in the data. This sensitivity occurs because FPs are global models: β values are assumed to be
constant over time.
3.2 Restricted cubic splines and Royston-Parmar models
A cubic spline represents a continuous function as a series of piecewise cubic polynomials [14],
hence relaxing the assumption of global time effects. Model flexibility is based on the number of
piecewise intervals (equivalently, the number of ‘knots’). For extrapolation, the cubic polynomial
from the last interval may be used, or it may be restricted to a linear function: this latter
assumption results in an RCS. An example specification is provided in the Appendix.
R-P models use RCSs, but not in the GLM framework. Typically the outcome is the log
cumulative hazard, which is monotonic. However, model estimates are not guaranteed to be
monotonic, so implausible values may result.
As they are not global models, splines may over-fit local ‘noise’ in the data [16], and there is in
general no closed test procedure for choosing between different models.
Prepared using sagej.cls
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4 Extensions to the generalised linear model
This section provides a brief overview of extensions to GLMs, with more details in the Appendix.
4.1 Generalised linear mixed models
A GLMM extends the GLM by incorporating random effect terms, which can help to quantify
the impact of unmeasured covariates and provide more realistic estimates of uncertainty. An
example of an FP(2) with a random-effect (denoted by bt) is:
E(yt) = FP(2) = β0 + bt + β1x
p1 + β2x
p2 , bt ∼ N(0, ψ
2)
GLMMs are also referred to as frailty models [17]. In theory, any GLMmay be extended by adding
a random term as shown above. The main limitation with GLMMs is that as the random effects
are not observed, there may be difficulties in model specification and parameter estimation.
4.2 Generalised additive models
A GAM is a GLM in which one or more of the covariates are modelled as a set of basis functions
[18]. For example, a univariate GAM is defined as:
E(yt) =
q∑
j=i
bj(t)βj = f(t)
Where bj(t) is the jth basis function, and q is the dimension of the basis function. Higher values
of q result in more flexible models. Both FPs and RCSs may be viewed as GAMs. The main
extension provided by a GAM is that model complexity is penalised during parameter estimation
(via shrinkage of the β). GAMs with a cubic spline basis have theoretical justification as being
approximate ‘smoothest interpolators’ [9] - see the Appendix for more details. Limitations of
GAMs will depend on the basis function used. For example, if a spline is used, the limitations
of these will still apply.
4.3 Dynamic generalised linear models and dynamic survival models
In a DGLM model coefficients (β) are allowed to vary over time. When applied to TTE data,
DGLMs are known as dynamic survival models (DSMs) [19]. Specification is (compare with
Equation 2a):
Observation model: E[yt] = µt × τt yt ∼ exponential family distribution (5a)
Response function: µt = h(x
T
t βt) (5b)
Transition model: βt = Fβt−1 + ζt (5c)
Initial conditions: β0 ∼MVN(b0,Z0) (5d)
where MVN denotes a multivariate Normal distribution, F is a function describing how the
coefficients evolve over time, and ζt is an error term - see the Appendix for further details.
DGLMs may be viewed as combining GLMs with time-series methods. In particular, parameter
Prepared using sagej.cls
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estimates may be based on minimising the error of within-sample extrapolations. This makes
these models particularly appealing when the primary objective of the analysis is extrapolation.
The main limitations with DGLMs are identifying suitable initial values, and convergence of
algorithms to estimate model coefficients [20, 19].
5 Theoretical comparison of approaches
Five different modelling approaches were considered: FPs, splines, GAMs, GLMMs, and DGLMs.
The frailty terms from a GLMM may be combined with either of the other four models. The
following prompts are provided to aid with choosing between the different approaches.
What is the primary objective of the analysis? If the main objective is in generating
extrapolations, this implies the use of a DGLM, as this is the only one of the models
for which parameter estimation is based on minimising forecasting error. If instead the
main objective is to provide estimates of the observed data, then any of the approaches
may be used.
Fractional polynomials or spline-based models? Spline-based models may be preferred
on theoretical grounds, as being approximate smoothest interpolators, whilst there are
a number of limitations with the use of FPs (see the Appendix). This suggests the use of
a spline-based model in preference to an FP within a GLM framework, with the latter as
a form of sensitivity analysis.
To penalize during or after estimation? Parameter estimation with a GAM automatically
penalises for model complexity, which helps to avoid over-fitting. Alternatively, information
criteria may be used. There are a number of different information criteria that could be
used, whereas GAMs have a specific objective function. The choice between these is likely
to be study specific: sometimes there may be good reasons to use a specific information
criteria, whilst in others the more automated approach of a GAM may be preferred.
For both approaches it is not possible to use significance tests to choose between model
specifications.
Are there any subject matter considerations? For example, there may be reason to
believe that there are important unmeasured confounders, which suggests incorporating
random effects. Or it may be thought that there will be important local fluctuations in
this hazard, which suggests the use of either a spline or dynamic model in preference to
the global FPs.
6 Empirical comparison of approaches
6.1 Dataset
We use a freely available dataset to demonstrate both the limitations of assuming linearity and
the use of more flexible models. Analyses were performed in R; the code used is available as
supplemental material. Hence the case-study is fully reproducible.
The data are on the survival of individuals following a diagnosis of breast cancer, and from a
Prepared using sagej.cls
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study conducted by the German Breast Cancer Study Group [21, 22]. Individuals with primary
node positive breast cancer were recruited between July 1984 and December 1989. Events
are defined as either cancer recurrence or death (from any cause). Data are available for 686
individuals, of which 299 experienced an event during follow-up. The maximum follow-up
was 7.28 years, with mean follow-up of 3.08 years. Use of GLMs requires that individual-level
data are restructured in the form of life tables. Samples of the individual-level data and the
corresponding (monthly) life table are provided in Tables 3 and 4, respectively. For Table 3, an
event indicator of one denotes that an event occurred (otherwise the indicator is zero, and the
outcome is time to censoring).
Table 3. A sample of the breast cancer data
Patient ID Outcome time (years) Event indicator
1 0.0219 0
...
...
...
15 0.1973 1
...
...
...
220 1.9562 1
221 1.9644 0
...
...
...
678 6.7288 1
...
...
...
686 7.2849 0
Table 4. Data from Table 3 restructured for Poisson regression
Month Sample size Events (µ) Censorings At risk (τ) Hazard (λ)
(0, 1) 686 0 7 682.5 0
(1, 2) 679 0 3 677.5 0
(2, 3) 676 1 4 674 0.001
...
...
...
...
...
...
(22, 23) 477 5 3 475.5 0.011
(23, 24) 469 7 4 467 0.015
(24, 25) 458 8 12 452 0.018
...
...
...
...
...
...
(87, 88) 1 0 1 0.5 0
As described in Section 2.2, the assumptions of linearity imposed by standard two-parameter
survival models may be unrealistic. To highlight this, we show model estimates against the
observed data in Figure 1 for each model (the one-parameter exponential model is not shown as
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it would only be appropriate if both the Weibull and Gompertz estimates had no slope). The
specification of the x and y axis is such that the model estimates form a straight-line. Figure 1
shows that the linear estimates generally provide a poor visual description of the data, with the
best description arising from the lognormal model.
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Figure 1. Breast cancer case-study: observed and modelled hazard
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6.2 Methods
We considered five broad classes of model:
FP models. We considered FP(2) models, with the complexity of the chosen model based on
the closed-test procedure, and the chosen powers based on minimising AIC.
Generalised linear mixed models. We fit FP models as described above, but we also
included frailty terms.
Spline-based models. Both RCS models and GAMs were considered. For the RCS model
between 1 and 5 internal knots were considered, with the choice based on minimising
AIC. For the GAM we considered two approaches to selecting the dimension of the basis
function: one used a fixed (arbitrary) value of 11 (v1), the other was based on minimising
AIC (v2). These two approaches were considered as some penalisation for over-fitting is
included during model-fitting, so it is unclear if model choice based on AIC is required. For
all models, the knots were placed at equally-spaced percentiles of the observed uncensored
death times [21].
Dynamic models. We examined three specifications: local-level, local-trend, and local-level
with global trend. There was no need to base model choice on minimising AIC (as the
data used to estimate the model parameters are separate to the objective function, which
is based on minimising one-step ahead forecasts).
Standard survival models. Eight survival models were considered: exponential, Weibull,
Gompertz, gamma, log-logistic, lognormal, generalised gamma, and generalised F. Results
are displayed for the three best fitting models (based on AIC). Note that the generalised
gamma and generalised F models have three and four parameters respectively, so are more
flexible than the standard survival models of Table 2.
The above choice of models was designed to be representative of the variety of different
approaches possible, but not exhaustive. All of the models used the natural logarithm of time
as the only covariate of interest (with the exception of the Gompertz, which uses time). All of
the GLM-models assumed a Poisson distribution with an exponential response function.
6.3 Goodness of fit
Goodness of fit (GoF) measures how well the statistical model describes the observed data.
It should be distinguished from predictive ability, which measures how well the model predicts
external data (such as future observations). One measure of GoF is Akaike’s information criterion
(AIC), which is defined as:
−2 logL+ 2k (6)
where L is the model likelihood and k is the number of parameters in the model [23]. Because
the likelihood is multiplied by a negative number, lower AIC values are to be preferred.
A number of variants on AIC have been proposed [23, 24]. An empirical study by Hyndman and
colleagues [24] compared five GoF measures, and noted that they all performed similarly. Further,
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Burnham and Anderson note that the AIC has strong theoretical motivation [23], whilst Jackson
and colleagues note that the AIC is preferable when models are used to represent complex
phenomena (such as survival processes) [25]. Due to having both empirical and theoretical
support, the AIC shall be used in this manuscript. Any GoF measure should be used in
combination with subject-matter considerations. In addition, estimates of the hazard function
were visually compared to the observed hazard function.
The AIC measures GoF to the observed data. It is unknown if models with a good within-
sample fit provide good extrapolations [14]. To measure the extrapolation performance of the
models we split the dataset into two parts. The first part considered events occurring within
the first three years, censoring all events after three years (half of the sample were at-risk of
an event at three years). Extrapolation performance was defined as the sum of squared errors
(SSE) between the model-estimate of the hazard and the observed hazard (calculated for monthly
intervals) for the remaining follow-up:
(
λˆt − λt
)2
, t ∈ {37 to 88 months} (7)
6.4 Results
Table 5 provides GoF values for each model and estimates of lifetime mean life expectancy. Two
AIC values are provided: one using the entire dataset, the other using the first three years. The
number of parameters is provided as a measure of model complexity: the two GAMs do not have
an integer number of parameters, as parameter effects are shrunk during model estimation. Plots
of the estimated hazard function for each model are displayed in Figure 2 for the observed data.
Corresponding extrapolations are given in Figure 3. As the best-fitting two-parameter standard
survival model (based on all the available data), the lognormal is provided as a black reference
line on all panes.
6.4.1 Within-sample goodness of fit All of the more flexible models provide lower AIC values
than the lognormal, although in general differences between values are small, and cannot be
tested for statistical significance. Visually, all of the models provide a good fit to the observed
data in Figure 2, although there is variation in the degree to which local fluctuations are captured.
Of the 11 models, the lowest AIC values arose from two DSMs. However, the third DSM had the
highest AIC of all the flexible models. This suggests that the extension to dynamic models can
lead to an improved GoF, but there is no guarantee that this will always occur. The next best
AIC values arose from the three spline-based models, which all had very similar GoF. However,
the two approaches to GAM estimation did result in markedly different models: the one with
automated fitting was more complex (with almost three times as many parameters) than the one
based on minimising AIC, whilst also providing a better absolute fit (based on log-likelihood).
Of the three standard survival models, the two generalised models (gamma and F) both provided
similar GoF, and both improved on the two-parameter models. Fit for the two FPs was similar
to that for the generalised gamma and generalised F survival models, and lower than that for
the spline-models. The inclusion of random effects had a negligible impact on the AIC.
Flexible parametric modelling of the hazard provides insight into how it varies over time. The
GAM (v1) and DSMs were slightly better at capturing local fluctuations in the hazard rate.
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This is most notable at approximately 1 and 1.5 years. However, as the most flexible models
considered, there is a danger that these local fluctuations represent noise. If this is the case then
the best-fitting models may be over-fitting the data, with no guarantee that this will lead to
improved extrapolations.
6.4.2 Extrapolation goodness of fit When fitting the 11 models to the first three years, the
ranking of the models was generally the same as for the full dataset, with the local level model
providing the lowest AIC, and the lognormal one of the highest. An exception is the DSM with
drift, which changes from having the second lowest AIC to the second highest. GoF to the
observed data did not predict extrapolation performance. For example, the lognormal and local
trend models both had the highest AIC values but the lowest SSEs. As with the AIC values, in
general there was little difference between SSE values. An exception is the DSM with a drift,
which provided poor extrapolations as it predicted an increasing trend.
In general the results in Table 5 demonstrate that there is little difference between the
competing models, both for within-sample and extrapolated GoF. However, Figure 3 shows
that resulting extrapolations (beyond the full data follow-up) can vary markedly by model.
Differences begin at about four years, and are likely to be due to the small patient numbers. For
example, at five years the sample size at risk is 113, at six years it is 34 and at seven years it
is three. When choosing between the models, it is very important to assess the plausibility of
the extrapolations with clinical experts, noting the outcome definition used. For this case-study
the mean age of the sample is 53 years and the outcome is either cancer recurrence or death
from any cause. The mean survival for German women of this age was 32.6 years in 2000 (the
oldest year for which there is data). This acts as an upper-bound on the likely survival of this
sample, as women with breast cancer are likely to have worse survival than the age-matched
general population, and cancer recurrences would further reduce the estimated survival. Of the
11 models considered, only the four which predicted an increasing extrapolated hazard (DSM
with drift, GAM with default settings, both FPs) gave a lifetime mean survival less than this.
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Table 5. Breast cancer case-study: log-likelihood and information criteria for the models
Model Log-likelihood Parameters AIC: full Data AIC: years 1-3 SSE: years 4-7 Life Expectancy
Local level -142.72 3 291.45 168.48 3.84 37.62
Local level with drift -142.09 4 292.19 180.25 18.58 23.41
GAM v2 -150.63 3.84 308.94 172.08 4.01 37.12
RCS -150.55 4 309.10 172.12 4.05 35.46
GAM v1 -144.05 10.66 309.42 173.89 3.81 14.13
Generalised Gamma -153.03 3 312.06 175.31 3.78 43.40
FP with random effects -152.13 4 312.27 173.54 4.25 15.70
FP -153.42 3 312.84 172.51 4.29 15.40
Generalised F -152.97 4 313.94 174.40 4.01 43.87
Local level local trend -152.36 5 314.71 180.68 3.76 41.61
Lognormal -157.55 2 319.11 179.42 3.73 40.64
AIC: Akaike’s information critera. FP(2): Second-order fractional polynomial. SSE: Sum of squared errors (× 10,000)
For derivation of SSE values see section 6.3
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Figure 2. Breast cancer case-study: observed and modelled hazard
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Figure 3. Breast cancer case-study: extrapolated hazards
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7 Discussion
A wide variety of flexible parametric models may be used to analyse and extrapolate TTE data
within a GLM framework, along with its extensions to GAMs, GLMMs and DGLMs. These
include FPs, spline based models and DSMs. An advantage of the GLM-based models over
standard survival models is that they can be made arbitrarily flexible as required to match
the complexity of the observed hazard function (for example, increasing the order of an FP or
the number of knots in a RCS). In contrast, to obtain more complex standard survival models,
different specifications are required (such as moving from a Weibull to a generalised gamma
model). Further, two of the GLM-extensions (GAMs and DGLMs) penalise for over-fitting as
part of parameter estimation [20, 9], thus removing much of the subjectivity over model choice.
To our knowledge, this is the first time that all of these approaches have been compared at both
a theoretical and an applied level, with recommendations to aid in choosing between the models.
The case-study demonstrated that it is straight-forward to perform a TTE analysis within
a GLM framework and that results are at least as good as, and often superior to, those from
standard survival models. However, differences in GoF were typically small, and in this example
there was no relationship between within-sample GoF and extrapolation performance. A strength
of the case-study is that we considered a variety of different statistical models, some of which
are currently infrequently used in survival analyses [3, 19]. The fully reproducible nature of the
case-studies shall help to increase the uptake of these more advanced methods.
There were marked differences in the ext apolations from each model, and hence estimates
of lifetime mean survival. Using external evidence, only the extrapolations from one each of
the DSMs and GAMs along with both FPs were plausible, whilst the best three standard
survival models all provided implausible extrapolations. This highlights a further benefit of the
GLM-approach, as it increases the potential to identify models which simultaneously provide
good within-sample fit and plausible extrapolations. Formally incorporating such evidence is an
important area of on-going research [26, 27]. However, this task is often non-trivial. For example,
external datasets may exist but they may not be fully generalizable to the decision problem. This
could be due to differences in the patient population, the healthcare system, or the time-period.
Hence this external dataset may need to be adjusted, and assumptions shall be required about
how the observed data relate to the external dataset.
Parametric analysis of TTE data typically has up to two objectives: to obtain a parsimonious
description of the observed data, and/or to predict outcomes for the unobserved future
(extrapolation). More work is required into the relative strengths and weaknesses of the
alternative models in both settings. For example, for the best-fitting FP model, inclusion of
random effects had a negligible impact on the AIC. Further research is required to see if this
is a general phenomenon, or if more nuanced modelling would lead to a more substantive
improvement in fit, or that these enhancements would be beneficial for other observed hazard
patterns. The case-study also highlights that a within-sample measure of GoF cannot be used
to choose between models for extrapolation, as has been observed previously [28, 29, 27]. The
case-study expands on these findings as it compares global models (FPs and survival models),
piecewise models (spline-based models), and local models (DSMs). Further work on model choice
when used for extrapolation could build upon the work of forecasting competitions [30].
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The case-study had limitations. First, we compared models based on AIC (within-sample)
and SSE (extrapolations). We were not able to test the differences for statistical significance.
For AIC, there is some guidance on what differences may be important, but this only holds
for nested models [23]. Whilst the more flexible models generally improved within-sample fit,
they did not improve extrapolation performance. In addition, for many analysts, use of the more
flexible models will come at an additional ‘cost’ as there will be a need to understand both the
theoretical details (strengths and limitations) of the method, as well as how to implement the
model. The guidance of Section 5 and the reproducible case-study should help to reduce these
costs, although they will still be a factor when choosing between the difference models.
The use of a single case-study may also be viewed as a limitation. It is unclear if the (generally)
superior GoF provided by DSMs and GAMs generalises to other settings. The results for the
three DSMs illustrate an important caution against generalisation: if only the two DSMs without
a local trend were considered then DSMs would provide the best-fitting models. In contrast, if
only the DSM with a local trend were considered than we would conclude that their fit is not
as good as spline-based models. The GoF of the DSM with drift also varied markedly between
using the full dataset and using the first three years of data. More experience with these different
models and their performance for different sample sizes and follow-up times is required before
firm conclusions can be made about which (if any) will provide more accurate estimates.
Conclusion
Parametric modelling of the hazard function allows for predictions of future outcomes. Standard
survival models may be insufficiently flexible to reflect the complexities of observed hazard
patterns. The GLM framework and its extension to GAMs, GLMMs and DGLMs can provide
insight into the structure of standard one- and two-parameter models, and their assumptions
of linearity. In addition to providing more flexible models (as we have demonstrated here), it
also allows for a rich class of model specifications via different combinations of the outcome,
distribution and response function - although this comes at the cost of needing to understand
how and when to implement these models. We have provided guidance to aid with choosing
between these models. Further, spline-based GLMs provide a useful alternative to R-P models:
with appropriate response function these models cannot estimate implausible negative hazards,
unlike R-P models. A motivating and fully reproducible case-study has demonstrated that
these currently under-used approaches can sometimes provide better GoF and more plausible
extrapolations than standard survival models.
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1 Flexible generalised linear models
This section describes flexible models that may be applied within a GLM framework, and hence
may be used for the analysis of survival data. To aid interpretation, the focus is on situations
where the only covariate of interest is time (a common occurrence in HTA), although extensions
to additional covariates are straight-forward. Subsequent sections describe extensions to GLMs.
1.1 Fractional polynomials
FPs have been developed to provide a systematic framework for identifying and modelling non-
linear effects of a continuous variable [1]. The degree of flexibility of an FP is defined by its order
(how many terms it includes). For a single variable, an ith order FP is defined as:
E(yt) = FP(i) = β0 +
i∑
j=1
βjx
pj (1)
where typically the powers pj are chosen from the set {-2, -1, -0.5, 0, 0.5, 1, 2, 3}, with x
0 denoting
log x. If the power of a term is duplicated then the duplicated term is multiplied by log x. Hence,
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for example, a second order FP of a single variable may be written as FP(2) = β0 + β1x
p1 + β2x
p2
if p1 6= p2 and FP(2) = β0 + β1x
p1 + β2x
p2 log x if p1 = p2. It is possible to consider FPs with
order > 2, and values of pj other than those described. However, in practice these extensions are
unlikely to lead to improvements in goodness of fit [2]. Similarly, other possible values for pj may
be considered, but may not. For any given order, the powers to use may be based on minimising
the AIC. To choose the order of FP, the following (approximate) closed test procedure may be
used [1]:
• Overall association of the outcome with time, comparing FP(2) model with model omitting
time (Non-significant result = stop testing, do not include time in model).
• Evidence for non-linearity, comparing FP(2) model with a model that is linear in time
(Non-significant result = stop testing, use a linear model: power = 1).
• Simpler or more complex non-linear model, comparing FP(2) model with FP(1) model
(Significant result = use FP(2) model, non-significant = use FP(1) model).
Comparisons are performed using likelihood ratio tests, with a pre-specified significance level. A
limitation of FPs is that, when using the eight powers described above, the continuous variable
has to be > 0. This is not a restriction for TTE data, but it can be a problem if transformations
of time are used. For example, the generalised F (and hence its special cases, which include the
generalised Gamma, Weibull, lognormal and log-logistic amongst others[3]) use the logarithm of
time, which can be negative. Of the eight powers described above, only five may be used with
negative values: {-2, -1, 1, 2, 3}. Further, it is not possible to handle repeated powers, which
would result in taking the lograithm of the covariate. Hence, for log time there are five FP(1)
models and 10 FP(2) models. For time as a covariate (no log transformation) there are eight
FP(1) models and 36 FP(2) models. If the closed test procedure rejects a non-linear model, and
a Poisson GLM is used, then the chosen model will be the same as a standard TTE model. A
linear model in time is analogous to a Gompertz model, a linear model in log-time is analogous to
a Weibull model, and a model without time as a covariate (and so just an intercept) is analogous
to an exponential.
1.1.1 Limitations Whilst FPs are flexible and relatively parsimonious, they have some
limitations:
• Insufficient power to detect non-linearity [1]
• Inability to model a variety of functional forms including logarithmic functions and
‘threshold effects’ [4]
• Lack of invariance with respect to the coding used for covariates: any transformations such
as centering or scaling can lead to different FPs being chosen [5]
• Reduced options for modelling covariates that can be positive.
• Sensitivity to extreme values in the data [6]
The last limitation can be a particular issue if extreme values occur near the end of follow-up
time, with subsequent implications for extrapolation.
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1.2 Restricted cubic splines and Royston-Parmar models
A cubic spline represents a continuous function as a series of piecewise cubic polynomials [7].
These cubic polynomials are restricted to join (have the same value) at a set of ‘knots’. The
complexity of the cubic polynomial representation depends on how many knots are used. There
will always be at least two knots, known as ‘boundary’ knots. Any additional knots are known
as ‘interior’ knots and occur between the boundary knots. Hence for k interior knots the knot
locations are ξmin < ξ1 < · · · < ξk < ξmax, with the boundary knots being {ξmin, ξmax}. Cubic
splines also have continuous first and second derivatives.
A RCS is further restricted to be linear beyond the boundary knots (that is, before ξmin and
after ξmax) [8]. A spline has several alternative formulations. One common description for an
RCS is as a truncated power series [8, 4]:
E(yt) = β0 + β1x+ β2V1(x) + · · ·+ βk+1Vk(x)
with Vj(x) = (x− kj)
3
+ − ψj(x− kmin)
3
+ − (1− ψj)(x− kmax)
3
+, j ∈ {1, . . . , k}
and ψj = (kmax − kj)/(kmax − kmin)
where (x− a)+ = max(0, x− a)
(2)
where the Vj(x) are referred to as basis functions. Alternative bases are formed by b-splines
or p-splines (which are a function of b-splines). B-splines are numerically more stable than the
truncated power series basis. However, in practice this advantage is usually negligible, and b-
splines cannot be used to generate extrapolations, whereas the truncated power series basis can
[4].
In the absence of any interior knots, an RCS is a linear function. Hence, as previously noted,
standard survival models may be obtained as special cases of RCSs. For extrapolations beyond
kmax the RCS is a linear function of x.
For a Poisson GLM, the outcome is the hazard rate. An alternative application of RCSs, outside
the GLM framework, is with an R-P model, for which the log cumulative hazard is the outcome
[8]. This is motivated by noting that the hazard function may be more noisy than the cumulative
hazard function. This increased noise is most likely near the end of follow-up time, due to small
numbers. These ‘end effects’ may induce spurious artefacts in the spline function. A drawback
of directly modelling the cumulative hazard is that this is monotonic (it cannot decrease), but
this property cannot be expressed by a simple set of constraints on the parameters of the spline.
Hence it is possible that implausible functions may be fitted, as a modelled decreasing cumulative
hazard would imply that there is a period for which the hazard rate is negative. An example
of implausible fit to real-data is provided in Figure 4b of [9]. Further developments of the R-P
model are described by Lambert and Royston [10, 7].
The model specification for a RCS includes both the number of internal knots, and also their
placement. It has been suggested that the former decision is more important than the latter
and that a maximum of three internal knots is usually sufficient, as larger values may lead to
over-fitting the data [8, 4]. When introducing the R-P model, the authors also suggested that
knots be placed at equally-spaced intervals of the uncensored event times (with the boundary
knots placed at the first and last of the observed uncensored event times)[8]. The choice of how
many interior knots to use is typically based on minimising an information criteria.
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1.2.1 Limitations The main limitation with RCS is that, due to their flexibility, they may over-
fit local ‘noise’ in the data [11]. The can also be ‘data hungry’, as they can produce biased results
in small samples [12]. In addition, unlike FPs, there is in general no closed test procedure for
choosing between different models. One exception is that linear models are always nested within
more complex models, so a test for non-linearity is possible.
2 Generalised linear mixed models
The presence of unmeasured variables can lead to heterogeneity (overdispersion) in the outcome
that is in excess of what is implied by a model. This will lead to underestimating uncertainty in
covariate effects [13]. To remedy this, GLMs may be extended by incorporating random effect
terms, resulting in GLMMs. These terms have a mean of zero and a variance parameter, usually
unknown. Frailty refers to the feature that individuals have unequal conditional probabilities of
experiencing the outcome of interest, given these random (frailty) terms. [14]. Frailty models are
appropriate when data are collected on multiple levels; for example individuals may be clustered
within families, or they may be clustered by centre within a multicentre clinical trial. Because
of this, frailty models may also be referred to as multi-level models [15].
Frailty models may be used to analyse TTE data outside a GLMM framework [13]. However,
with the GMLM framework, frailty models may be modelled as mixed models, which have been
extensively researched [16, 17]. Mixed models are so-called as they contain both fixed effects and
random effects. Fixed effects occur in a standard GLM; for these effects (parameter coefficients)
are assumed to apply (are fixed) for all individuals. In contrast, random effects are allowed
to vary across individuals. To avoid identifiability issues, it may be assumed that the random
effects are drawn from a zero-mean Normal distribution (other zero-mean distributions such as
t-distribution may also be used).
As an example, consider a fixed-effects 2nd-order FP which, if powers are not duplicated, may
be written as:
E(yt) = FP(2) = β0 + β1x
p1 + β2x
p2
When analysing TTE data with a GLM, individual observations relate to individual time
intervals. As there is only one observation per time-interval, a GLMM with a random intercept
may be used. That is, the linear predictor in any time-interval t is increased or decreased by an
additive amount bt. For example:
E(yt) = FP(2) = β0 + bt + β1x
p1 + β2x
p2 , bt ∼ N(0, ψ
2) (3)
The above extension is not specific to FP models. That is, any fixed-effects GLMmay be extended
by adding a random intercept as shown above.
2.1 Limitations
As the frailty terms are not observed, it may not be possible to identify them from the data, which
can lead to problems with model specification and estimation. [13, 18]. A further limitation with
the use of frailty models is that it is unclear how random effect terms should be extrapolated.
One option is to fit a model to the estimated random effects and use this to predict future values.
Alternatively the last estimated random effect may be carried-forwards.
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3 Generalised additive models
A generalised additive model (GAM) may be viewed as a GLM in which a covariate x is replaced
by a linear combination of a finite set of smooth functions b1, . . . , bq [19]. For example, a univariate
GAM is defined as:
E(yt) =
q∑
j=i
bj(t)βj = f(t) (4)
Where bj(t) is the jth basis function, and q is the dimension of the basis function. Modelling
the effect of a covariate as a sum of basis functions results in extremely flexible models, with
more flexible models arising as more functions are added to the basis. The basis functions may
be non-parametric, which results in semi-parametric GAMs [19]. However, the focus here is on
parametric basis functions, and hence parametric GAMs [20].
Of the parametric basis functions, use of RCSs is of particular interest. Model estimation for a
GAM is different to that for a GLM. For the latter, model complexity may be penalised after
model fitting via the use of information criteria, such as the AIC. For a GAM, model complexity
is included in the objective function to be minimised. For example, for Normally distributed
data this would be [20]:
n∑
t=1
(
yt − f(t)
)2
+ Λ
∫ (
f ′′(t)
)2
dt (5)
The integral for the second term is taken over the range of the data and penalises the wiggliness of
function, to avoid over-fitting the data. The first term in equation (5) quantifies model goodness
of fit. In this example it is the sum of squared errors, but a more general representation uses a
negative log-likelihood, as is used in a GLM. This leads to the following objective function [21]:
−2
n∑
t=1
Lt
(
yt; f(t)
)
+ Λ
∫ ∞
−∞
(
f ′′(t)
)2
dt (6)
As with AIC, the objective function measures the trade-off between model goodness of fit and
model complexity. The key difference is that for GAMs the complexity of the model is estimated
during the model-fitting process, and is not a post-hoc choice. For a GAM, Λ quantifies this
trade-off. As Λ→∞ the estimated function tends towards a straight line. For Λ = 0 there is no
penalty on the regression spline (so the resulting model will be equivalent to a RCS model if a
RCS basis is used).
There are two components to model estimation, as the smoothing parameter Λ and the model
coefficients β are estimated separately [20]. One approach to estimating the degree of smoothing is
based on a generalisation of leave-one-out cross-validation, known as generalised cross-validation.
For given values of Λ, model coefficients are estimated based on penalised likelihood estimation
[22].
As with standard GLM models, GAMs may also be extended to incorporate random effects.
The resulting models are known as generalised additive mixed models [23]. This extension does
not result in any concepts additional to those outlined in section 2.
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3.1 Choice of basis function
A full RCS (with a knot at each unique value of t) has the desirable property of being a ‘smoothest
interpolator’ [20]. That is, for all functions that are continuous over the range of the data and
also have an absolutely continuous first derivative, a full RCS will minimise equation (6) [21]. In
addition, a RCS is usually flexible enough to adequately describe most functions. An alternative
choice of basis function is to use polynomials. Here the jth basis function is defined as [20]:
bj(t) = t
j−1 (7)
In comparison with equation (2), the basis for polynomials is much simpler. The first two terms
are also the same as for a RCS, and so the use of polynomial basis functions also includes standard
models such as the Weibull and Gompertz as special cases. However, the use of polynomial basis
functions is not recommended [20, 4]. Unlike RCSs, there is no guarantee that polynomials will
provide an adequate fit across the entire range of the data. Further, the fit in a local region
of the data can be strongly affected by the characteristics of the data in other regions. Also,
polynomials are unable to provide adequate descriptions of a number of functions, such as those
including ‘threshold effects’ or logarithmic functions. It should be noted that FPs (section 1.1)
do not follow the hierarchical rule that is used when constructing polynomial basis functions.
Indeed, FPs include fractional powers, which are not in the definition of a polynomial basis
function in equation (7). Hence, unlike R-P models, FPs cannot be viewed as a special case
of a GAM. As such the limitations that apply to the use of polynomial basis functions do not
necessarily apply to the use of FPs.
3.2 Regression splines
A full smoothing spline has as many parameters as there are data points. These full splines may
be approximated by regression splines, which are no longer ‘smoothest interpolators’, but are
computationally easier to fit [20]. A simulation study comparing full splines with their regression
approximation found that the approximation led to a superior fit (to the known ‘true’ function)
[24]. The author attributed this counter-intuitive finding to the fact that regression splines
are also less likely to overfit the data (or equivalently, the full splines was modelling random
variation).
When using regression splines, the basis dimension has to be specified (it is not part of model
estimation). In practice the smoothing parameter Λ in equation (6) has a larger impact on model
complexity than the choice of basis dimension. Hence the basis dimension acts as an upper-bound
for model complexity. Provided it is sufficiently large, model results are typically insensitive to
the choice of basis dimension [20]. A slight exception is that larger basis dimensions lead to a
larger set of candidate models, which can sometimes affect model choice.
3.3 Limitations
When using RCSs as basis functions, GAMs share the same limitation in that they require
sufficiently large datasets, and they may over-fit local noise in the data [24]. However, the use of
a penalized objective function slightly mitigates this latter limitation.
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4 Dynamic generalised linear models and dynamic survival models
A DGLM extends a GLM by allowing the model coefficients to vary as a smooth function of
time. These may be used to analyse TTE data, resulting models are known as dynamic survival
models (DSMs). As an illustrative example, consider the exponential model: log(µt) = β0. This
may be interpreted as a global level model as the outcome is set to a fixed level for all times.
This assumption can be relaxed by allowing β0 to vary over time. Hence log(µt) = β0,t, giving a
local-level model.
Without further restrictions, this may lead to an over-fitting model. For example, setting β0,t = yt
would give a perfect fit to the observed data. However, this will over-fit the data, so to avoid
this the following restriction is used:
• When estimating the local level at time t, only evidence available prior to time t is
used. This can include previous estimates of the local level, previous covariate values,
and previous observations.
More formally, at time t, let the prior available evidence be denoted by the history of
prior outcomes: H(y)t = {y1, y2, . . . , yt−1}, the history of prior coefficient estimates H(β)t =
{β1, β2, . . . , βt−1}, and the history of prior covariates H(x)t = {x1, x2, . . . , xt−1}. Then the
estimate of the local level at time t is obtained as a function of all these historiesH(y, β, x)t,= Ht
for simplicity.
This estimate is a forecast (extrapolation) from the evidence at time t− 1 to time t. As such, it
is referred to as a one-step-ahead forecast.
The approach of DSMs represents a small, but significant change in estimation from previously
described approaches. For these, a model estimate of yt (denoted by yˆt) used all the observed
data. Such an estimate is known as a smoothed estimate, and models minimised the error of
smoothed estimates. In contrast, DSMs minimise the error of (within-sample) forecasts. Hence
the choice between a DSM and a GLM (or GAM) is likely to be based on if the analyst wants
to minimise the error of smoothed estimates or the error of forecasts.
Some further comments on the use of the forecasts are required.
• It shall be assumed that the Markov property is valid [25]; so yˆt|1:t−1 = yˆt|t−1. In addition,
sometimes an estimate at time t uses yt. This is no longer a one-step ahead forecast, but
is referred to as a filtered estimate, denoted as yˆt|1:t = yˆt|t.
• When estimating the one-step ahead forecast yˆt+1|t, evidence is available for all the prior
one-step ahead forecasts (which are a function of the βt). However, evidence is also available
on the previous outcomes. This may be used to estimate the accuracy of the previous
forecasts, and this knowledge used to improve estimates of yˆt+1|t. Hence the one-step
ahead forecast yˆt+1|t is based on prior filtered values, and so the histories H(β)t include
filtered values, not one-step ahead forecasts.
• Specification of a DSM requires initial (starting) estimates. There will be no histories to
inform these, so they may be based on external data, expert opinion, or via a heuristic
[26].
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A limitation with DSMs is that model estimation can be difficult: either due to computational
issues, or if the use of approximate methods is inappropriate [27, 28]. Extrapolations from a DSM
are determined by the chosen model specification, which is described in the following subsections.
4.1 Model specification
The general model specification for a DGLM (or DSM) is [21]:
Observation model: E[yt] = µt yt ∼ exponential family distribution (8a)
Response function: µt = h(x
T
t βt) (8b)
Transition model: βt = Fβt−1 + ζt (8c)
Initial conditions: β0 ∼MVN(b0, Z0) (8d)
where MVN denotes a multivariate Normal distribution, F is a transition matrix for the
coefficients over time, and the error term (ζt), also referred to as an innovation, is assumed to
be an independent and identically distributed series with ζt ∼ N(0, Zt), where Zt is a variance-
covariance matrix of the model coefficients. As before, for a Poisson GLM, the outcome is the
number of number of events in an interval (which, combined with knowledge of the at-risk
population, can be used to derive the hazard rate). Of note, the covariate time does not appear
within the model specification. That is, no assumptions are made about the relationship between
time and the hazard rate. Instead it is assumed that there exist latent states (the βs), such as
an average value (level) and trend - either of which may vary over time.
Three types of DLM are of particular interest. Two are the local level and local trend models,
which may be interpreted as zero-order and first-order Taylor series approximations, respectively
[26]. The third is the local level global trend model, also referred to as a local level with drift
model. These are defined below.
4.1.1 Local level models
E(yt) = βt
βt = βt−1 + ζt
this type of model is referred to as a random-walk model. Extrapolations of the yt are a constant
value, equal to the last-estimated local level. That is, the extrapolated value h time steps into
the future, given observed data up to time T is yˆT+h|T = βT ,
4.1.2 Local trend (linear) models These may be defined as:
E(yt) = x
Tβt = [1, 0]
[
β1t
β2t
]
= β1t
βt =
[
β1t
β2t
]
=
[
1 1
0 1
] [
β1,t−1
β2,t−1
]
+
[
ζ1t
ζ2t
]
β1t = β1,t−1 + β2,t−1 + ζ1,t
β2t = β2,t−1 + ζ2,t
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where βt = [β1t, β2t]
T , ζt = [ζ1t, ζ2t]
T . The formula for β1t may be written down recursively as:
β1t = β1,t−1 + β2,t−1 + ζ1,t
= β1,t−2 + 2β2,t−2 + ζ1,t + ζ1,t−1 + ζ2,t−1
= β1,t−3 + 3β2,t−3 + ζ1,t + ζ1,t−1 + ζ1,t−2 + ζ2,t−1 + 2ζ2,t−2
= . . .
= β1,0 + tβ2,0 +
t∑
i=1
ζ1i +
t−1∑
j=1
jζ2,t−j
where the first two terms are a linear function, and the last 2 terms are random error. As
such, β1t represents the local level, which is a linear function of t. The parameter β2t may
be interpreted as the growth rate (local trend). Extrapolations are a linear function of the
last-estimated local level and local trend values: yˆT+h|T = β1T + hβ2T .
4.1.3 Local level global trend (drift) models This may be viewed as a special case of the local
trend model, with ζ2,t = 0. A single trend β2 is then estimated based on all the data. This
estimate of the trend will be more stable than the one estimated locally as towards the end of
follow-up the number of observations is smallest. However, this increased stability is at the loss
of flexibility, as the estimate of trend is fixed and so does not vary with time.
4.2 Likelihood specification
The likelihood for a DSM may be written as the product of likelihoods for individual time-periods
j (denoted by Lj), with tj denoting the jth time-period. Following Hemming and Shaw [29] the
following two variables are introduced:
δij =
{
δi if t
∗
i ≤ tj
0 if t∗i > tj
tij =
{
ti if t
∗
i ≤ tj
tj if t
∗
i > tj
(9)
hence for an individual who experienced an event, δij = 1 for all time periods up-to and including
the time period which included the event. In all other situations it is zero. The indicator tij is
the observed survival time up-to and including the time period which included the observation.
Subsequently it is set equal to the time interval. The likelihood for a Poisson DSM is then:
L =
N∏
j=i
Lj =
N∏
j=i
τj∏
i=i
exp(−[tij − tj−1]e
xTt βj )ex
T
t βjδij (10)
where N is the number of time-intervals, and τj is the set of individuals who have a survival
time ≥ tj . When equal interval widths are used, this is the same likelihood as for a Poisson GLM
with an offset (see Section 5).
4.3 Limitations
The flexibility of allowing model coefficients to vary as a function of time can lead to problems
with both convergence, and specification of initial estimates [30, 31, 29, 28].
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5 Likelihood estimation
5.1 Parametric survival models
Let di be an event indicator which = 1 if ti is an observed survival time and = 0 if ti is a
right-censored observation (hence the true survival time will be greater than ti). The likelihood
is then [32]:
Li =
{ ∏
i: di=1
fi(ti)
∏
i: di=0
Si(ti)
}
(11)
For individuals with an observed event their probability density function contributes to the
likelihood. Individuals with censored times contribute their cumulative survivor function (as
their probability density function is not fully observed but it is known that they survived up to
time ti). The log-likelihood contribution for the i
th patient is:
logLi = log
{
f(ti)
diS(ti)
1−di
}
= di log{f(ti)}+ (1− di) log{S(ti)}
(12)
The following identities may be used to derive an expression of the likelihood purely in terms of
the hazard function [33]: S(t) = 1−
∫ t
0
f(u)du and f(t) = h(t)× S(t). This gives:
logLi = log
{
h(ti)
diS(ti)
}
= di log{h(ti)} −
∫ ti
0
h(u)du
(13)
5.2 Equivalence between a Poisson GLM with an offset and a Poisson DSM
5.2.1 Poisson GLM with an offset. The probability density function is:
f(yi; τiθ) =
τiθ
yie−τiθ
yi!
The likelihood L is equal to the sum of the yi. Taking logarithms and re-arranging gives:
L =
∏(τiθyie−τiθ
yi!
)
logL =
∑[
log
(
τiθ
yie−τiθ
yi!
)]
=
∑[
log(τiθ
yi) + log(e−τiθ)− log(yi!)
]
=
∑
[yi log(τiθ)− τiθ − log(yi!)]
=
∑
[yi log(τi) + yi log(θ)− τiθ − log(yi!)]
The first and last terms do not include the parameter θ. Thus, for a given dataset, the first
and last terms will always be the same, and so may be eliminated from the likelihood when
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comparing different models. This gives the likelihood:
logL =
∑
[yi log(θ)− τiθ] (14)
5.2.2 Poisson DSM. Consider the Poisson DSM likelihood for any given time-period.
Lj =
τj∏
i=i
exp(−[tij − tj−1]e
zβj )ezβjδij
Assume that intervals are all of the same width, so that the term [tij − tj−1] = 1 and may be
omitted. Taking logarithms:
logLj =
τj∑
i=i
log
[
exp(−ezβj )ezβjδij
]
=
τj∑
i=i
log[exp(−ezβj )] + log(ezβjδij )
=
τj∑
i=i
−ezβj + zβjδij
= djzβj − τje
zβj
where dj is the observed number of events in the jth time-interval, hence = yj . Let θj = e
zβj .
Then:
logLj = yj log(θj)− τjθj (15)
which is the same as applying equation (14) to a single time-period.
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